The Heart -- Barcelona, Spain - Early results for the Nevo sirolimus-eluting stent (Johnson & Johnson) are reviving hopes for a concept in stent design that seemed headed for the scrap heap, despite wide agreement that the idea—drug reservoirs dispersed throughout the stent—made sense.
